Loading compound...

Small molecule inhibitor

Taladegib is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential use in treating conditions such as idiopathic pulmonary fibrosis, various types of cancer, and small cell lung carcinoma.

How it worksTaladegib is a small molecule that works by inhibiting specific biological targets related to cell growth and disease progression.

Used for
Idiopathic pulmonary fibrosisVarious types of cancer (neoplasms)Small cell lung carcinomaCancer metastasis
Conditions
idiopathic pulmonary fibrosisneoplasmcancermetastasissmall cell lung carcinoma
Class
Small moleculeSmall molecule inhibitorRespiratoryOncology

How to take

Taladegib is currently in clinical development (max phase 2) and is not yet an FDA-approved medication for general use.

Talk to your doctor

Questions to ask

  • ·Is Taladegib a candidate for my specific type of cancer?
  • ·What are the current clinical trial results for Taladegib and pulmonary fibrosis?
  • ·How does Taladegib differ from other lung cancer treatments?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.